Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Dec;102(3):445–447. doi: 10.1111/j.1365-2249.1995.tb03835.x

Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD)

T T MacDonald
PMCID: PMC1553355  PMID: 8536355

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aluwihare A. P. Electron microscopy in Crohn's disease. Gut. 1971 Jul;12(7):509–518. doi: 10.1136/gut.12.7.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berg R. D. Mechanisms confining indigenous bacteria to the gastrointestinal tract. Am J Clin Nutr. 1980 Nov;33(11 Suppl):2472–2484. doi: 10.1093/ajcn/33.11.2472. [DOI] [PubMed] [Google Scholar]
  3. Berg R. D., Savage D. C. Immune responses of specific pathogen-free and gnotobiotic mice to antigens of indigenous and nonindigenous microorganisms. Infect Immun. 1975 Feb;11(2):320–329. doi: 10.1128/iai.11.2.320-329.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dubos R. The microbiota of the gastrointestinal tract. Gastroenterology. 1966 Nov;51(5):868–874. [PubMed] [Google Scholar]
  5. Duchmann R., Kaiser I., Hermann E., Mayet W., Ewe K., Meyer zum Büschenfelde K. H. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol. 1995 Dec;102(3):448–455. doi: 10.1111/j.1365-2249.1995.tb03836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Foo M. C., Lee A. Immunological response of mice to members of the autochthonous intestinal microflora. Infect Immun. 1972 Oct;6(4):525–532. doi: 10.1128/iai.6.4.525-532.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Giaffer M. H., Holdsworth C. D., Duerden B. I. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut. 1992 May;33(5):646–650. doi: 10.1136/gut.33.5.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Klasen I. S., Melief M. J., van Halteren A. G., Schouten W. R., van Blankenstein M., Hoke G., de Visser H., Hooijkaas H., Hazenberg M. P. The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease. Clin Immunol Immunopathol. 1994 Jun;71(3):303–308. doi: 10.1006/clin.1994.1090. [DOI] [PubMed] [Google Scholar]
  9. Kühn R., Löhler J., Rennick D., Rajewsky K., Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993 Oct 22;75(2):263–274. doi: 10.1016/0092-8674(93)80068-p. [DOI] [PubMed] [Google Scholar]
  10. Miller A., Lider O., Weiner H. L. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med. 1991 Oct 1;174(4):791–798. doi: 10.1084/jem.174.4.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Moreau M. C., Ducluzeau R., Guy-Grand D., Muller M. C. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect Immun. 1978 Aug;21(2):532–539. doi: 10.1128/iai.21.2.532-539.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Peach S., Lock M. R., Katz D., Todd I. P., Tabaqchali S. Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group. Gut. 1978 Nov;19(11):1034–1042. doi: 10.1136/gut.19.11.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Roe T. F., Coates T. D., Thomas D. W., Miller J. H., Gilsanz V. Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med. 1992 Jun 18;326(25):1666–1669. doi: 10.1056/NEJM199206183262504. [DOI] [PubMed] [Google Scholar]
  14. Rutgeerts P., Hiele M., Geboes K., Peeters M., Penninckx F., Aerts R., Kerremans R. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology. 1995 Jun;108(6):1617–1621. doi: 10.1016/0016-5085(95)90121-3. [DOI] [PubMed] [Google Scholar]
  15. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A. C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993 Oct 22;75(2):253–261. doi: 10.1016/0092-8674(93)80067-o. [DOI] [PubMed] [Google Scholar]
  16. Wensinck F., Custers-van Lieshout, Poppelaars-Kustermans P. A., Schröder A. M. The faecal flora of patients with Crohn's disease. J Hyg (Lond) 1981 Aug;87(1):1–12. doi: 10.1017/s0022172400069187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yamada T., Sartor R. B., Marshall S., Specian R. D., Grisham M. B. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology. 1993 Mar;104(3):759–771. doi: 10.1016/0016-5085(93)91011-6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES